Cost Effectiveness of Paricalcitol versus a Non-Selective Vitamin D Receptor Activator for Secondary Hyperparathyroidism in the UK - Concepedia

Concepedia

Publication | Closed Access

Cost Effectiveness of Paricalcitol versus a Non-Selective Vitamin D Receptor Activator for Secondary Hyperparathyroidism in the UK

30

Citations

32

References

2010

Year

Mark Nuijten, Dennis L. Andress, Steven E. Marx, Alistair Curry, Raimund Sterz

Clinical Drug Investigation

Secondary HyperparathyroidismMedicineParathyroid HormoneParathyroid DiseaseParathyroid GlandCost EffectivenessPharmacology

References

	Year	Citations

Page 1